Skip to Content Skip to Content
Attorney General of Virginia Header

View Office of the Attorney General Expenditures



Lock Up Your Meds
News for CitizensOcwen MortgageMortgage Servicing Settlement Agreement
Computer Crime
Human Trafficking
Gang Prevention
Drug Take Back Program Line of Duty Death Claims
Medicaid Fraud
Elder Abuse and Neglect
TRIAD - Seniors
Official Opinions


State Seal
Commonwealth of Virginia
Office of the Attorney General

name and titleaddress



For media inquiries only, contact:  Brian J. Gottstein
Email: (best contact method)
Phone: 804-786-5874


Attorney General Cuccinelli announces $100 million settlement with Abbott Laboratories

~Illegal off-label marketing of anti-seizure drug Depakote resulted in
largest consumer protection pharmaceutical settlement ever reached~

RICHMOND (May 7, 2012) – Today, Attorney General Ken Cuccinelli was joined by 44 states and the District of Columbia in announcing a $100 million settlement with Abbott Laboratories for the illegal off-label marketing of its drug Depakote. This agreement marks the largest consumer protection-based pharmaceutical settlement ever reached. 

Depakote is approved for treatment of seizure disorders, mania associated with bipolar disorder, and prophylaxis of migraines. However, the attorneys general alleged Abbott marketed the drug for unapproved uses, including treatment of schizophrenia, agitated dementia, and autism.

Under the terms of the settlement, the Commonwealth of Virginia will receive more than $2 million. Funds received in this settlement will help fund future consumer protection enforcement matters. 

Abbott Laboratories, based in Illinois, will be restricted from marketing the drug for off-label uses not approved by the U.S. Food and Drug Administration (FDA). The company will also pay $100 million nationally.

Under the settlement, Abbott Laboratories is:

In addition, for a five-year period Abbott must:

“My office is committed to enforcing Virginia’s consumer protection laws,” said Cuccinelli. “The laws are designed to benefit both consumers and honest businesses, and to ensure that customers have full and accurate information in the marketplace. This settlement sends a clear message to companies that are willing to cut corners to make a dollar: this type of activity will not be tolerated in Virginia. It will also ensure that pharmaceutical companies do not illegally market their drugs for uses not approved by the FDA.”

Attorneys general of the District of Columbia and the following states participated in today’s settlement:  Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin.

More about Attorney General Cuccinelli

Photos of the attorney general

A copy of this news release may be found on the attorney general's web site here.

Follow the Office of the Attorney General's official posts on Facebook:  

facebook logo and link

# # #